Additionally, the variant rs2267401 has been shown to increase gallbladder cancer and hepatocellular carcinoma risk, likely by increased APOBEC3B expression that arises through heightened promoter activity and IL-6 response [43, 86]. Here, APOBEC3B is linked to hepatocellular carcinoma.